NCT01990209 2022-06-30Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)SCRI Development Innovations, LLCPhase 2 Completed71 enrolled 23 charts